当前位置：首页 > 科学研究 > 科研进展

宋伟宏组Experimental And Molecular Medicine发文ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer's disease

时间：2025-06-30 09:18:08 暂无来源浏览量：263

宋伟宏 EAM1.png

原文链接：https://www.nature.com/articles/s12276-025-01455-8

上一篇

苏建忠组Advanced Science发文NKX2-5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation

下一篇

王朝组Journal Of The American Chemical Society发文Rabies Virus Targeting NIR-II Phototheranostics

相关推荐

叶方富组Smart Medicine发文Isoliquiritigenin ...

宋伟宏组BMC Psychiatry发文Smoking impairs co...

薛伟组Solar Energy Materials and Solar Ce...

苏建忠组Science Translational Medicine发文Id...

黄志锋组Advanced Science发文FGF2 Mediated US...